GE Healthcare Technologies, Inc. (GEHC)
69.72
-0.84
(-1.19%)
USD |
NASDAQ |
Sep 03, 16:00
69.42
-0.30
(-0.43%)
After-Hours: 20:00
GE Healthcare Technologies Research and Development Expense (TTM) : 1.283B for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.283B |
| March 31, 2026 | 1.262B |
| December 31, 2025 | 1.261B |
| September 30, 2025 | 1.282B |
| June 30, 2025 | 1.306B |
| March 31, 2025 | 1.331B |
| December 31, 2024 | 1.311B |
| September 30, 2024 | 1.282B |
| Date | Value |
|---|---|
| June 30, 2024 | 1.288B |
| March 31, 2024 | 1.259B |
| December 31, 2023 | 1.205B |
| September 30, 2023 | 1.161B |
| June 30, 2023 | 1.099B |
| March 31, 2023 | 1.058B |
| December 31, 2022 | 1.026B |
| September 30, 2022 | 980.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Globus Medical, Inc. | 147.06M |
| Butterfly Network, Inc. | 38.10M |
| Intuitive Surgical, Inc. | 1.414B |
| Sensus Healthcare, Inc. | 6.40M |
| Varex Imaging Corp. | 91.40M |